Exploring the role of readthrough-inducing molecule 2,6-diaminopurine to increase immune response against cancer cells.

Sandoval Pacheco C, Leroy AM, Derhourhi M, Cardon T, Leroy C, Jouy N, Com E, Guevel B, Bourette R, Carrard J, Barros D, Duchêne B, Toussaint B, Froguel P, Jonckheere N, Chassat T, Van Seuningen I, Lavigne R, Pineau C, Pierre P, Soncin F, Salzet M, Bonnefond A, Lejeune F

Open source

DOI: 10.1016/j.ymthe.2025.09.024
Published: 2025 Dec 3
Container: Molecular therapy : the journal of the American Society of Gene Therapy
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ymthe.2025.09.024,
  title = {Exploring the role of readthrough-inducing molecule 2,6-diaminopurine to increase immune response against cancer cells.},
  author = {Sandoval Pacheco C and Leroy AM and Derhourhi M and Cardon T and Leroy C and Jouy N and Com E and Guevel B and Bourette R and Carrard J and Barros D and Duchêne B and Toussaint B and Froguel P and Jonckheere N and Chassat T and Van Seuningen I and Lavigne R and Pineau C and Pierre P and Soncin F and Salzet M and Bonnefond A and Lejeune F},
  year = {2025},
  journal = {Molecular therapy : the journal of the American Society of Gene Therapy},
  doi = {10.1016/j.ymthe.2025.09.024},
  url = {https://doi.org/10.1016/j.ymthe.2025.09.024}
}

RIS

TY  - JOUR
TI  - Exploring the role of readthrough-inducing molecule 2,6-diaminopurine to increase immune response against cancer cells.
AU  - Sandoval Pacheco C
AU  - Leroy AM
AU  - Derhourhi M
AU  - Cardon T
AU  - Leroy C
AU  - Jouy N
AU  - Com E
AU  - Guevel B
AU  - Bourette R
AU  - Carrard J
AU  - Barros D
AU  - Duchêne B
AU  - Toussaint B
AU  - Froguel P
AU  - Jonckheere N
AU  - Chassat T
AU  - Van Seuningen I
AU  - Lavigne R
AU  - Pineau C
AU  - Pierre P
AU  - Soncin F
AU  - Salzet M
AU  - Bonnefond A
AU  - Lejeune F
PY  - 2025
JO  - Molecular therapy : the journal of the American Society of Gene Therapy
DO  - 10.1016/j.ymthe.2025.09.024
UR  - https://doi.org/10.1016/j.ymthe.2025.09.024
ER  -

APA

C, S. P., AM, L., M, D., T, C., C, L., N, J., E, C., B, G., R, B., J, C., D, B., B, D., B, T., P, F., N, J., T, C., I, V. S., R, L., C, P., P, P., F, S., M, S., A, B., & F, L. (2025). Exploring the role of readthrough-inducing molecule 2,6-diaminopurine to increase immune response against cancer cells.. Molecular therapy : the journal of the American Society of Gene Therapy. https://doi.org/10.1016/j.ymthe.2025.09.024

Source records

pubmed · retrieved 2026-09-25T12:35:53.775Z